Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial-Reference-Cited by-同舟云学术

Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial

Published:2024-08 Issue:8 Volume:12 Page:e1288-e1299
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Zaman Khalequ,Julin Cathinka Halle,Aziz Asma Binte,Stene-Johansen Kathrine,Yunus Md,Qadri Firdausi,Gurley Emily S,Sandbu Synne,Øverbø Joakim,Dembinski Jennifer L,Laake Ida,Bhuiyan Taufiqur R,Rahman Mustafizur,Haque Warda,Khanam Mahbuba,Clemens John D,Dudman Susanne

Funder

Research Council of Norway

Publisher

Elsevier BV

Reference30 articles.

1. The global burden of hepatitis E virus genotypes 1 and 2 in 2005;Rein;Hepatology,2012

2. Hepatitis E: an underestimated emerging threat;Webb;Ther Adv Infect Dis,2019

3. Hepatitis E virus;Emerson;Rev Med Virol,2003

4. Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis;Bigna;BMC Pregnancy Childbirth,2020

5. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes—a systematic review;Bergløv;J Viral Hepat,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: Age-period-cohort analysis 2021;Journal of Infection;2024-10

2. Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial;The Lancet Global Health;2024-08

3. Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings;The Lancet Global Health;2024-07